Reference
Arai S, et al. Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder Cancer. Case Reports in Oncology 11: 450-460, No. 2, May 2018. Available from: URL: http://doi.org/10.1159/000490458 - Japan
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1737, 43 (2019). https://doi.org/10.1007/s40278-019-57138-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57138-7